0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Ophthalmic Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-13H8167
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global and Japan Ophthalmic Medicine Market Insights Forecast to 2027
BUY CHAPTERS

Ophthalmic Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13H8167
Report
November 2024
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Ophthalmic Medicine - Market Size

The global market for Ophthalmic Medicine was estimated to be worth US$ 1897 million in 2023 and is forecast to a readjusted size of US$ 2545 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030

Ophthalmic Medicine - Market

Ophthalmic Medicine - Market

There are several diseases that can affect the eyes, and often, the kind of treatment required is medication that you put directly into them. It is called “ophthalmic” and often comes in the form of drops, gel or ointment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ophthalmic Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ophthalmic Medicine by region & country, by Type, and by Application.
The Ophthalmic Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Medicine.
Market Segmentation

Scope of Ophthalmic Medicine - Market Report

Report Metric Details
Report Name Ophthalmic Medicine - Market
Forecasted market size in 2030 US$ 2545 million
CAGR 4.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Eye Drops
  • Eye Ointment
  • Gelling Agent
  • Tablet
  • Injection
Segment by Application
  • Anti-fatigue and Dryness
  • Cataract
  • Anti-infective
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novaliq, Shenyang Xingqi Pharmaceutical Co.,Ltd., Zhejiang Shapuaisi Pharmaceutical, Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Bausch Health, Alcon NV, Mentholatum
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Ophthalmic Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Ophthalmic Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Ophthalmic Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Ophthalmic Medicine - Market size in 2030?

Ans: The Ophthalmic Medicine - Market size in 2030 will be US$ 2545 million.

Who are the main players in the Ophthalmic Medicine - Market report?

Ans: The main players in the Ophthalmic Medicine - Market are Novaliq, Shenyang Xingqi Pharmaceutical Co.,Ltd., Zhejiang Shapuaisi Pharmaceutical, Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Bausch Health, Alcon NV, Mentholatum

What are the Application segmentation covered in the Ophthalmic Medicine - Market report?

Ans: The Applications covered in the Ophthalmic Medicine - Market report are Anti-fatigue and Dryness, Cataract, Anti-infective

What are the Type segmentation covered in the Ophthalmic Medicine - Market report?

Ans: The Types covered in the Ophthalmic Medicine - Market report are Eye Drops, Eye Ointment, Gelling Agent, Tablet, Injection

1 Market Overview
1.1 Ophthalmic Medicine Product Introduction
1.2 Global Ophthalmic Medicine Market Size Forecast
1.2.1 Global Ophthalmic Medicine Sales Value (2019-2030)
1.2.2 Global Ophthalmic Medicine Sales Volume (2019-2030)
1.2.3 Global Ophthalmic Medicine Sales Price (2019-2030)
1.3 Ophthalmic Medicine Market Trends & Drivers
1.3.1 Ophthalmic Medicine Industry Trends
1.3.2 Ophthalmic Medicine Market Drivers & Opportunity
1.3.3 Ophthalmic Medicine Market Challenges
1.3.4 Ophthalmic Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ophthalmic Medicine Players Revenue Ranking (2023)
2.2 Global Ophthalmic Medicine Revenue by Company (2019-2024)
2.3 Global Ophthalmic Medicine Players Sales Volume Ranking (2023)
2.4 Global Ophthalmic Medicine Sales Volume by Company Players (2019-2024)
2.5 Global Ophthalmic Medicine Average Price by Company (2019-2024)
2.6 Key Manufacturers Ophthalmic Medicine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Ophthalmic Medicine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ophthalmic Medicine
2.9 Ophthalmic Medicine Market Competitive Analysis
2.9.1 Ophthalmic Medicine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Ophthalmic Medicine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Medicine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Eye Drops
3.1.2 Eye Ointment
3.1.3 Gelling Agent
3.1.4 Tablet
3.1.5 Injection
3.2 Global Ophthalmic Medicine Sales Value by Type
3.2.1 Global Ophthalmic Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ophthalmic Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Ophthalmic Medicine Sales Value, by Type (%) (2019-2030)
3.3 Global Ophthalmic Medicine Sales Volume by Type
3.3.1 Global Ophthalmic Medicine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Ophthalmic Medicine Sales Volume, by Type (2019-2030)
3.3.3 Global Ophthalmic Medicine Sales Volume, by Type (%) (2019-2030)
3.4 Global Ophthalmic Medicine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Anti-fatigue and Dryness
4.1.2 Cataract
4.1.3 Anti-infective
4.2 Global Ophthalmic Medicine Sales Value by Application
4.2.1 Global Ophthalmic Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ophthalmic Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Ophthalmic Medicine Sales Value, by Application (%) (2019-2030)
4.3 Global Ophthalmic Medicine Sales Volume by Application
4.3.1 Global Ophthalmic Medicine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Ophthalmic Medicine Sales Volume, by Application (2019-2030)
4.3.3 Global Ophthalmic Medicine Sales Volume, by Application (%) (2019-2030)
4.4 Global Ophthalmic Medicine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Ophthalmic Medicine Sales Value by Region
5.1.1 Global Ophthalmic Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ophthalmic Medicine Sales Value by Region (2019-2024)
5.1.3 Global Ophthalmic Medicine Sales Value by Region (2025-2030)
5.1.4 Global Ophthalmic Medicine Sales Value by Region (%), (2019-2030)
5.2 Global Ophthalmic Medicine Sales Volume by Region
5.2.1 Global Ophthalmic Medicine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Ophthalmic Medicine Sales Volume by Region (2019-2024)
5.2.3 Global Ophthalmic Medicine Sales Volume by Region (2025-2030)
5.2.4 Global Ophthalmic Medicine Sales Volume by Region (%), (2019-2030)
5.3 Global Ophthalmic Medicine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Ophthalmic Medicine Sales Value, 2019-2030
5.4.2 North America Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Ophthalmic Medicine Sales Value, 2019-2030
5.5.2 Europe Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Ophthalmic Medicine Sales Value, 2019-2030
5.6.2 Asia Pacific Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Ophthalmic Medicine Sales Value, 2019-2030
5.7.2 South America Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ophthalmic Medicine Sales Value, 2019-2030
5.8.2 Middle East & Africa Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ophthalmic Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ophthalmic Medicine Sales Value
6.2.1 Key Countries/Regions Ophthalmic Medicine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Ophthalmic Medicine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Ophthalmic Medicine Sales Value, 2019-2030
6.3.2 United States Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ophthalmic Medicine Sales Value, 2019-2030
6.4.2 Europe Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ophthalmic Medicine Sales Value, 2019-2030
6.5.2 China Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ophthalmic Medicine Sales Value, 2019-2030
6.6.2 Japan Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ophthalmic Medicine Sales Value, 2019-2030
6.7.2 South Korea Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ophthalmic Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ophthalmic Medicine Sales Value, 2019-2030
6.9.2 India Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novaliq
7.1.1 Novaliq Company Information
7.1.2 Novaliq Introduction and Business Overview
7.1.3 Novaliq Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novaliq Ophthalmic Medicine Product Offerings
7.1.5 Novaliq Recent Development
7.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
7.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
7.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Introduction and Business Overview
7.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Offerings
7.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Development
7.3 Zhejiang Shapuaisi Pharmaceutical
7.3.1 Zhejiang Shapuaisi Pharmaceutical Company Information
7.3.2 Zhejiang Shapuaisi Pharmaceutical Introduction and Business Overview
7.3.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Offerings
7.3.5 Zhejiang Shapuaisi Pharmaceutical Recent Development
7.4 Chengdu Kanghong Pharmaceutical Group
7.4.1 Chengdu Kanghong Pharmaceutical Group Company Information
7.4.2 Chengdu Kanghong Pharmaceutical Group Introduction and Business Overview
7.4.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Offerings
7.4.5 Chengdu Kanghong Pharmaceutical Group Recent Development
7.5 Santen Pharmaceutica
7.5.1 Santen Pharmaceutica Company Information
7.5.2 Santen Pharmaceutica Introduction and Business Overview
7.5.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Santen Pharmaceutica Ophthalmic Medicine Product Offerings
7.5.5 Santen Pharmaceutica Recent Development
7.6 Bausch Health
7.6.1 Bausch Health Company Information
7.6.2 Bausch Health Introduction and Business Overview
7.6.3 Bausch Health Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Bausch Health Ophthalmic Medicine Product Offerings
7.6.5 Bausch Health Recent Development
7.7 Alcon NV
7.7.1 Alcon NV Company Information
7.7.2 Alcon NV Introduction and Business Overview
7.7.3 Alcon NV Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Alcon NV Ophthalmic Medicine Product Offerings
7.7.5 Alcon NV Recent Development
7.8 Mentholatum
7.8.1 Mentholatum Company Information
7.8.2 Mentholatum Introduction and Business Overview
7.8.3 Mentholatum Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Mentholatum Ophthalmic Medicine Product Offerings
7.8.5 Mentholatum Recent Development
8 Industry Chain Analysis
8.1 Ophthalmic Medicine Industrial Chain
8.2 Ophthalmic Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ophthalmic Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Ophthalmic Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Ophthalmic Medicine Market Trends
    Table 2. Ophthalmic Medicine Market Drivers & Opportunity
    Table 3. Ophthalmic Medicine Market Challenges
    Table 4. Ophthalmic Medicine Market Restraints
    Table 5. Global Ophthalmic Medicine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Ophthalmic Medicine Revenue Market Share by Company (2019-2024)
    Table 7. Global Ophthalmic Medicine Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Ophthalmic Medicine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Ophthalmic Medicine Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Ophthalmic Medicine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Ophthalmic Medicine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Ophthalmic Medicine
    Table 13. Global Ophthalmic Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Medicine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Ophthalmic Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Ophthalmic Medicine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Ophthalmic Medicine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Ophthalmic Medicine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Ophthalmic Medicine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Ophthalmic Medicine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Ophthalmic Medicine Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Ophthalmic Medicine Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Ophthalmic Medicine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Ophthalmic Medicine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Ophthalmic Medicine Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Ophthalmic Medicine Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Ophthalmic Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Ophthalmic Medicine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Ophthalmic Medicine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Ophthalmic Medicine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Ophthalmic Medicine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Ophthalmic Medicine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Ophthalmic Medicine Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Ophthalmic Medicine Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Ophthalmic Medicine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Ophthalmic Medicine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Ophthalmic Medicine Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Ophthalmic Medicine Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Ophthalmic Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Ophthalmic Medicine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Ophthalmic Medicine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Ophthalmic Medicine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Ophthalmic Medicine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Ophthalmic Medicine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Ophthalmic Medicine Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Ophthalmic Medicine Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Ophthalmic Medicine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Ophthalmic Medicine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Ophthalmic Medicine Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Ophthalmic Medicine Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Ophthalmic Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Ophthalmic Medicine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Ophthalmic Medicine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Ophthalmic Medicine Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Ophthalmic Medicine Sales Volume, (2025-2030) & (K Units)
    Table 57. Novaliq Company Information
    Table 58. Novaliq Introduction and Business Overview
    Table 59. Novaliq Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Novaliq Ophthalmic Medicine Product Offerings
    Table 61. Novaliq Recent Development
    Table 62. Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
    Table 63. Shenyang Xingqi Pharmaceutical Co.,Ltd. Introduction and Business Overview
    Table 64. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Offerings
    Table 66. Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Development
    Table 67. Zhejiang Shapuaisi Pharmaceutical Company Information
    Table 68. Zhejiang Shapuaisi Pharmaceutical Introduction and Business Overview
    Table 69. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Offerings
    Table 71. Zhejiang Shapuaisi Pharmaceutical Recent Development
    Table 72. Chengdu Kanghong Pharmaceutical Group Company Information
    Table 73. Chengdu Kanghong Pharmaceutical Group Introduction and Business Overview
    Table 74. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Offerings
    Table 76. Chengdu Kanghong Pharmaceutical Group Recent Development
    Table 77. Santen Pharmaceutica Company Information
    Table 78. Santen Pharmaceutica Introduction and Business Overview
    Table 79. Santen Pharmaceutica Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Santen Pharmaceutica Ophthalmic Medicine Product Offerings
    Table 81. Santen Pharmaceutica Recent Development
    Table 82. Bausch Health Company Information
    Table 83. Bausch Health Introduction and Business Overview
    Table 84. Bausch Health Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Bausch Health Ophthalmic Medicine Product Offerings
    Table 86. Bausch Health Recent Development
    Table 87. Alcon NV Company Information
    Table 88. Alcon NV Introduction and Business Overview
    Table 89. Alcon NV Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Alcon NV Ophthalmic Medicine Product Offerings
    Table 91. Alcon NV Recent Development
    Table 92. Mentholatum Company Information
    Table 93. Mentholatum Introduction and Business Overview
    Table 94. Mentholatum Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Mentholatum Ophthalmic Medicine Product Offerings
    Table 96. Mentholatum Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Ophthalmic Medicine Downstream Customers
    Table 100. Ophthalmic Medicine Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ophthalmic Medicine Product Picture
    Figure 2. Global Ophthalmic Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Ophthalmic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Ophthalmic Medicine Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Ophthalmic Medicine Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Ophthalmic Medicine Report Years Considered
    Figure 7. Global Ophthalmic Medicine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Ophthalmic Medicine Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Ophthalmic Medicine Revenue in 2023
    Figure 10. Ophthalmic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Eye Drops Picture
    Figure 12. Eye Ointment Picture
    Figure 13. Gelling Agent Picture
    Figure 14. Tablet Picture
    Figure 15. Injection Picture
    Figure 16. Global Ophthalmic Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Ophthalmic Medicine Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Ophthalmic Medicine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 19. Global Ophthalmic Medicine Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Ophthalmic Medicine Price by Type (2019-2030) & (US$/Unit)
    Figure 21. Product Picture of Anti-fatigue and Dryness
    Figure 22. Product Picture of Cataract
    Figure 23. Product Picture of Anti-infective
    Figure 24. Global Ophthalmic Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Ophthalmic Medicine Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Ophthalmic Medicine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Ophthalmic Medicine Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Ophthalmic Medicine Price by Application (2019-2030) & (US$/Unit)
    Figure 29. North America Ophthalmic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Ophthalmic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Ophthalmic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Ophthalmic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Ophthalmic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Ophthalmic Medicine Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Ophthalmic Medicine Sales Volume (%), (2019-2030)
    Figure 41. United States Ophthalmic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Ophthalmic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Ophthalmic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Ophthalmic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Ophthalmic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Ophthalmic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Ophthalmic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Ophthalmic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Ophthalmic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Ophthalmic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Ophthalmic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Ophthalmic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Ophthalmic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Ophthalmic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 62. Ophthalmic Medicine Industrial Chain
    Figure 63. Ophthalmic Medicine Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global 5α-Reductase Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8L18969
Thu Jan 23 00:00:00 UTC 2025

Add to Cart

Global Divalproex Sodium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13K9340
Tue Jan 21 00:00:00 UTC 2025

Add to Cart

Global Autoimmune Disease Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32R18714
Tue Jan 21 00:00:00 UTC 2025

Add to Cart

Global Buprenorphine Hydrochloride Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39E9005
Tue Jan 21 00:00:00 UTC 2025

Add to Cart